22.01.2015 Views

Annual Activities Report 2011 - INCT-Inofar - UFRJ

Annual Activities Report 2011 - INCT-Inofar - UFRJ

Annual Activities Report 2011 - INCT-Inofar - UFRJ

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Annual</strong> <strong>Report</strong> <strong>2011</strong> | <strong>INCT</strong>-INOFAR<br />

42<br />

Highlights<br />

It was elected after screening of functionalized 1,3-benzodioxolyl-N-phenylpiperazine derivatives,<br />

synthesized from natural safrole, and unsubstituted-phenyl analogues in functional phenylephrineinduced<br />

vasoconstriction of rabbit aorta rings bioassays. The determination of LASSBio-772 affinity for<br />

alpha 1A (rat salivary gland) and alpha 1B (rat liver) subtypes, through displacement of [ 3 H]prazosin<br />

specific binding, led us to obtain IC 50<br />

values of 0.14 nM for the alpha 1A, similar to that displayed<br />

by tamsulosin (IC 50<br />

= 0.13 nM) [3], and 5.55 nM for the alpha 1B-AR, representing a 40-fold higher<br />

affinity for alpha 1A over alpha 1B, in contrast to 14.8-fold for tamsulosin. LASSBio-772 also presented<br />

high affinity (K B<br />

= 0.025 nM) for the alpha 1D-AR subtype in functional rat aorta assays, showing to be<br />

equipotent to tamsulosin (K B<br />

= 0.017 nM).<br />

Considering that LASSBio-772 showed an alpha<br />

1-AR antagonistic action in vitro, we decided to<br />

evaluate its effect in vivo. Analyzing the impact<br />

of LASSBio-772 upon arterial blood pressure as<br />

compared to a reference nonselective alpha 1-AR<br />

antagonist (prazosin), both at the same dose (100<br />

μg/kg), we observed that the hypotensive effect of<br />

LASSBio-772 was significantly smaller than the<br />

one induced by prazosin.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!